Nov 05, 2019 9:00am EST CohBar Completes Phase 1a and Initiates Phase 1b Stage of Clinical Trial of CB4211 Under Development for NASH and Obesity
Oct 24, 2019 9:00am EDT CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019
Jul 31, 2019 4:05pm EDT CohBar to Announce 2019 Second Quarter Financial Results and Provide Business Update on August 7, 2019
Jun 10, 2019 9:00am EDT CohBar poster available on preclinical results showing efficacy of a new family of mitochondria based therapeutics in a type 2 diabetes model as presented at the American Diabetes Association 79th Scientific Sessions
Jun 05, 2019 9:00am EDT CohBar to Hold 2019 Annual Shareholder Meeting and Investor Update June 18, 2019